Add to favorites

#Industry News

Combating Influenza: Enhancing Diagnostics for Global Health

Advancing Detection Technology to Protect Against Influenza Outbreaks

November 1 is World Flu Day! Let's raise awareness about the importance of enhancing diagnostic capabilities to combat this highly contagious respiratory virus!

Influenza, commonly known as the flu, impacts millions of people globally each year. It is caused by influenza viruses, primarily types A, B, and C, with Type A being most prone to cause epidemics. The flu spreads through respiratory droplets, making it easily transmissible, especially in close-contact environments.

Rapid and precise detection of influenza strains is crucial for effective treatment and containment of outbreaks. Tianlong is at the forefront of diagnostic innovation, offering a comprehensive nucleic acid detection solution designed to identify and distinguish between multiple influenza strains.

Our detection kit includes coverage for Influenza A and B, Influenza C, as well as various subtypes, such as A(H1&H3), A(H1N1), A(H3N2), and A(H5N1). Moreover, our advanced multiplex kit enables simultaneous detection of Influenza A/B, Human Adenovirus, and 2019-nCoV, which is especially effective in distinguishing between flu and other viral infections with overlapping symptoms.

Together, we can reduce the impact of influenza and keep our communities healthy. Stay safe and healthy!

Combating Influenza: Enhancing Diagnostics for Global Health

Details

  • Xi'An, Shaanxi, China
  • Xi'an TianLong Science and Technology Co.. Ltd.